K Number
K203743
Device Name
EXA
Date Cleared
2021-12-10

(353 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
EXA™ is a software device that receives digital images and data from various sources (i.e. CT scanners, ultrasound systems, R/F Units, computed & direct radiographic devices, secondary capture devices, scanners, imaging gateways or other imaging sources). Images and data can be stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images are not intended for diagnostic review. Mammographic images should only be viewed with a monitor cleared by FDA for viewing mammographic images. For primary diagnosis, post process DICOM "for presentation" images must be used.
Device Description
EXA™ is a software suite of web based PACS applications that was developed specifically to handle the DICOM protocol, for both transmitting and viewing DICOM images and data elements. The applications were developed so that access to the PACS can occur from any Microsoft Windows computer with internet capabilities and offer an interface that users find to be quite intuitive after some initial learning. (Not intended for use on mobile devices) The EXA™ applications deal with all manner of DICOM images and modalities, including MR, CT, CR, US, MG and many others. These images can be viewed, annotated, transmitted to other facilities, printed, animated and stored using the EXA™ PACS suite.
More Information

Not Found

No
The document describes a standard PACS software for image storage, communication, processing, and display, with no mention of AI, ML, or related concepts.

No.
This device is described as a software suite for handling and displaying medical images and data, primarily for diagnostic review and communication, not for delivering a therapeutic effect.

Yes

The device description indicates that the system is used for "viewing DICOM images and data elements" from various imaging modalities (MR, CT, CR, US, MG), and the "Intended Use / Indications for Use" section states that "Images and data can be stored, communicated, processed and displayed within the system". While it mentions that "Lossy compressed mammographic images are not intended for diagnostic review" and "For primary diagnosis, post process DICOM 'for presentation' images must be used," it still handles and processes images that are used for diagnosis, implying it plays a role in the diagnostic workflow. The primary function of viewing and processing medical images for "primary diagnosis" fits the definition of a diagnostic device.

Yes

The device is explicitly described as a "software device" and a "software suite of web based PACS applications." The description focuses solely on the software's functionalities for handling, processing, and displaying digital images and data from various imaging sources, without mentioning any proprietary hardware components included with the device.

Based on the provided information, this device is likely an IVD (In Vitro Diagnostic) in the broader sense of the term as used by regulatory bodies like the FDA, but it is not a traditional IVD that analyzes biological samples.

Here's why:

  • Intended Use: The intended use clearly states that the software receives, stores, communicates, processes, and displays digital images and data from various medical imaging sources. This data is used for diagnostic review (with specific caveats for mammography). This places the device squarely in the realm of providing information used in the diagnostic process.
  • Device Description: The description highlights its function as a PACS (Picture Archiving and Communication System) for handling and viewing DICOM images from various modalities. PACS systems are integral to the workflow of medical imaging and diagnosis.
  • Processing of Images: The mention of "processed" images further supports its role in potentially manipulating or enhancing images for diagnostic interpretation.
  • Intended User: The intended users are "trained professionals, nurses, and technicians," who are involved in the healthcare and diagnostic process.
  • Predicate Device: The predicate device listed is K142919 EXA™, which is the same device. This indicates that this is likely a submission for a modification or update to an existing device that has already been classified and regulated. Looking up K142919 would likely confirm its regulatory classification.

Why it's not a traditional IVD:

Traditional IVDs typically involve the analysis of biological samples (blood, urine, tissue, etc.) to detect diseases or conditions. This device deals with medical images, which are a different type of diagnostic information.

Regulatory Context:

Regulatory bodies like the FDA classify medical devices based on their intended use and risk. Software that processes and displays medical images for diagnostic purposes is considered a medical device and falls under their purview. While not a "traditional" IVD in the sense of analyzing biological samples, it functions as a diagnostic tool by providing information used in the diagnostic process.

In summary, while not a traditional IVD that analyzes biological samples, this device is a medical device that plays a crucial role in the diagnostic process by handling and displaying medical images. It is highly likely regulated as a medical device by bodies like the FDA, and its function aligns with the broader concept of providing information for diagnosis.

N/A

Intended Use / Indications for Use

EXA™ is a software device that receives digital images and data from various sources (i.e. CT scanners, ultrasound systems, R/F Units, computed & direct radiographic devices, secondary capture devices, scanners, imaging gateways or other imaging sources). Images and data can be stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images are not intended for diagnostic review. Mammographic images should only be viewed with a monitor cleared by FDA for viewing mammographic images. For primary diagnosis, post process DICOM "for presentation" images must be used.

Product codes

LLZ

Device Description

EXA™ is a software suite of web based PACS applications that was developed specifically to handle the DICOM protocol, for both transmitting and viewing DICOM images and data elements. The applications were developed so that access to the PACS can occur from any Microsoft Windows computer with internet capabilities and offer an interface that users find to be quite intuitive after some initial learning. (Not intended for use on mobile devices) The EXA™ applications deal with all manner of DICOM images and modalities, including MR, CT, CR, US, MG and many others. These images can be viewed, annotated, transmitted to other facilities, printed, animated and stored using the EXA™ PACS suite.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

CT scanners, ultrasound systems, R/F Units, computed & direct radiographic devices, secondary capture devices, scanners, imaging gateways or other imaging sources.

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Typical users of this system are trained professionals, nurses, and technicians.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The results of software validations after each version update that the new version of software is as safe and effective as our predicate software device. Software validations for each version update demonstrate that the specifications and performance of the device is as functional and effective as the legally marketed predicate device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

EXA™ - K142919

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Konica Minolta Healthcare Americas, Inc. % Mr. Scott Blood Director of Regulatory Services MEDicept, Inc. 200 Homer Avenue ASHLAND MA 01721

December 10, 2021

Re: K203743

Trade/Device Name: EXA™ Regulation Number: 21 CFR 892.2050 Regulation Name: Medical image management and processing system Regulatory Class: Class II Product Code: LLZ Dated: November 11, 2021 Received: November 12, 2021

Dear Mr. Blood:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for

1

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

For

Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K203743

Device Name EXATM

Indications for Use (Describe)

EXA™ is a software device that receives digital images and data from various sources (i.e. CT scanners, ultrasound systems, R/F Units, computed & direct radiographic devices, secondary capture devices, scanners, imaging gateways or other imaging sources). Images and data can be stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images are not intended for diagnostic review. Mammographic images should only be viewed with a monitor cleared by FDA for viewing mammographic images. For primary diagnosis, post process DICOM "for presentation" images must be used.

Typical users of this system are trained professionals, nurses, and technicians.

Type of Use (Select one or both, as applicable)× Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image shows the logo for MEDICEPT. The word "MEDI" is in large, bold, blue letters, and the word "CEPT" is in a stylized, purple font. Below the company name is the text "Trusted Solutions, Rapid Response" in a smaller font.

K203743

510(K) SUMMARY

This 510(k) Summary is in accordance with the requirements of the Safe Medical Device Act (SMDA) of 1990. The content of this 510(k) summary is provided in conformance with 21 CFR § 807.92. This Summary was prepared on December 21, 2020.

1. Submitter's Information

Name: Carolyn Russell QA Manager Konica Minolta Healthcare Americas, Inc.

Address: 2217 Us Highway 70 E Garner, NC 27529

Phone: 919.792.6420 x2351

Official FDA Contact:

MEDIcept Inc. 200 Homer Ave Ashland, MA 01721 Scott Blood sblood@medicept.com 978.729.5978

2. Device Identification

Proprietary - Tradename: EXATM

Classification Name: Picture Archiving and Communications System

Medical imaging management and processing system

Product Code: LLZ, Class II

Regulation: 892.2050

Common/Usual Name: PACS System

4

Image /page/4/Picture/0 description: The image is a logo for MEDICEPT. The word "MEDI" is in blue, and the word "CEPT" is in purple. Below the word MEDICEPT is the phrase "Trusted Solutions, Rapid Response" in a smaller font. The word "Trusted Solutions" is in gray, and the word "Rapid Response" is in purple.

Legally Marketed Predicate Device 3.

EXA™ - K142919

The predicate has not been subject to a design-related recall.

Indications for Use (Proposed Device) 4.

EXA™ is a software device that receives digital images and data from various sources (i.e. CT scanners, MR scanners, ultrasound systems, R/F Units, computed & direct radiographic devices, secondary capture devices, scanners, imaging gateways or other imaging sources). Images and data can be stored, communicated, processed and displayed within the system and or across computer networks at distributed locations. Lossy compressed mammographic images are not intended for diagnostic review. Mammographic images should only be viewed with a monitor cleared by FDA for viewing mammographic images. For primary diagnosis, post process DICOM "for presentation" images must be used. Typical users of this system are trained professionals, nurses, and technicians.

Device Description 5.

EXA™ is a software suite of web based PACS applications that was developed specifically to handle the DICOM protocol, for both transmitting and viewing DICOM images and data elements. The applications were developed so that access to the PACS can occur from any Microsoft Windows computer with internet capabilities and offer an interface that users find to be quite intuitive after some initial learning. (Not intended for use on mobile devices) The EXA™ applications deal with all manner of DICOM images and modalities, including MR, CT, CR, US, MG and many others. These images can be viewed, annotated, transmitted to other facilities, printed, animated and stored using the EXA™ PACS suite.

6. Substantial Equivalence Discussion

The results of software validations after each version update that the new version of software is as safe and effective as our predicate software device.

| Characteristic | EXATM - K142919
(Predicate device) | EXATM - This submission
(Subject device) |
|----------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| FDA Product Code | LLZ | LLZ |
| Indications for Use | EXATM is a software device that
receives digital images and data from | EXATM is a software device that
receives digital images and data from |
| Characteristic | EXA TM - K142919
(Predicate device) | EXA TM - This submission
(Subject device) |
| | various sources (i.e. CT scanners, MR
scanners, ultrasound systems, R/F
Units, computed & direct radiographic
devices, secondary capture devices,
scanners, imaging gateways or other
imaging sources). Images and data can
be stored, communicated, processed
and displayed within the system and or
across computer networks at distributed
locations. Lossy compressed
mammographic images are not
intended for diagnostic review.
Mammographic images should only be
viewed with a monitor cleared by FDA
for viewing mammographic images.
For primary diagnosis, post process
DICOM "for presentation" images must
be used. Typical users of this system
are trained professionals, nurses, and
technicians. | various sources (i.e. CT scanners, MR
scanners, ultrasound systems, R/F
Units, computed & direct radiographic
devices, secondary capture devices,
scanners, imaging gateways or other
imaging sources). Images and data can
be stored, communicated, processed
and displayed within the system and or
across computer networks at distributed
locations. Lossy compressed
mammographic images are not
intended for diagnostic review.
Mammographic images should only be
viewed with a monitor cleared by FDA
for viewing mammographic images.
For primary diagnosis, post process
DICOM "for presentation" images must
be used. Typical users of this system
are trained professionals, nurses, and
technicians. |
| Configuration | Submission was for software only | Same |
| Film Digitizer | No film digitizer is part of the system | No film digitizer is part of the system |
| DICOM | DICOM 3.0 | DICOM 3.0 |
| Compression | Wavelet/JPEG2000 | JPEG2000 lossless |
| Improvements to
Perform Imaging
Work | YES
• The ability to rotate of MIP in MPR
mode was the added function.
• Verify Multiplanar reconstruction | YES
• Added ability to scan images at
Order Level
• Added ability to draw Quick3D
Spine label annotation on axial
images
• Added option in Viewer to export
images to AVI format |
| Expanded GUI
Interface to Integrate
More Effectively
with the web | YES
• Expanded GUI Interface for users
changes to allow client EXA to
function with Web | YES
• SDE Report formatting in GUI |
| Language Capability | YES
• Ability to use multilingual interface
to client's operating system (i.e
foreign country multi-language | YES
• Improved code to better handle date
formats in various languages |
| Characteristic | EXA TM - K142919
(Predicate device) | EXA TM - This submission
(Subject device) |
| | Allows interpretation of Spanish and Portuguese | Internationalized program error codes to prepare for localization |
| Worklist Expansion | YES | YES |
| Web Worklist Client Worklist | Web Work list- includes most of the advanced study list features and the entire Image Viewing features, but cannot create Patient CDs or Import images and scanned documents. Verify Client Worklist- Includes all the advanced Study List and Image Viewing features mentioned above. Available modules in the client worklist provide the following: Sending and Receiving images over phone line, local area networks and the Internet. Included in this includes DICOM transmission/receive | Change worklist column grid to use viewer globe icon & add approved report link, Add a new approved report column to 'My Exams' and 'Group Exams' worklist allowing a user to view the approved report if one exists Add a new column, Study Status, to all worklist grids on physician portal, Add a new Study Status column that shows the study status of each study. It should use a dropdown for filtering. Add the Study Status column as an option in the filter manager Add Export function to Worklist - Add the ability to Export search/filtered results from the main studies Worklist |
| Verify PACS
Backend - DICOM
Improvements | YES Ability to add clarity to DICOM images has been allowed | YES The EXA PACS/RIS viewer now supports vendor-specific names for 2D synthesized views (CView, V-Preview,and Insight View). Improved code-level image request handling to increase performance of the EXA PACS/RIS viewer |
| Improvements to
Panel Guide PACS -
UAI Multifunctional
Interface | YES | NO |
| Module Updates | YES Peer Review-Allows a radiologist to review a report from a second radiologist Exam Report Module functions per specification | NO |
| Computer | PC | Same |
| Power Source | AC Line (PC Required) | Same |

5

Image /page/5/Picture/0 description: The image shows the logo for MEDICept. The first part of the logo, "MEDIC" is in blue, and the second part, "EPT" is in purple. Below the logo is the text "Trusted Solutions, Rapid Response".

6

Image /page/6/Picture/0 description: The image shows the logo for MEDICept. The word "MEDIC" is in large, bold, blue letters, and the word "EPT" is in large, bold, purple letters. Below the logo is the text "Trusted Solutions, Rapid Response" in a smaller font.

7

Image /page/7/Picture/0 description: The image shows the logo for MEDICEPT. The word "MEDICEPT" is written in large, bold letters, with "MEDI" in blue and "CEPT" in purple. Below the logo, the words "Trusted Solutions, Rapid Response" are written in a smaller, gray font.

The EXA software was developed per the following standards:

  • . IEC 62304:2015 Medical Device software - Software life cycle process
  • ISO 14971:2007 Medical Devices - Application of Risk Management to Medical Devices

This EXA software premarket submarket submission was prepared using the following CDRH guidance documents:

  • Content of Premarket Submissions for Management of Cybersecurity in Medical ● Devices Guidance for Industry and Food and Drug Administration Staff Document Issued on: October 2, 2014
  • . Guidance for Industry and FDA Staff Guidance for the Content of Premarket Submissions for Software contained in Medical Devices, Document issued on: May 11,2005 Medical Devices, Document issued on: May 11, 2005

7. Conclusion

Based upon fact that the Viztek EXA™ and the Konica Minolta Healthcare Americas EXA™ is the same software, and the version updates made to the EXA software did not change the Intended Use of the software, it can be concluded the Konica Minolta Healthcare Americas EXA is substantially equivalent to the identified predicate device Viztek EXA in terms of intended use, safety and effectiveness. Software validations for each version update demonstrate that the specifications and performance of the device is as functional and effective as the legally marketed predicate device. Therefore, it is concluded that this system is substantially equivalent to the legally marketed predicate device.